The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine

Ketamine and esketamine (SPRAVATO) are rapid acting antidepressants that have gained evidence and popularity in recent years in treating depression, and are under investigation for other psychiatric indications. Ketamine is a potential drug of abuse and the addiction potential of these medications h...

Full description

Bibliographic Details
Main Authors: Jay Wang, Atul Khullar, Roger S. McIntyre, Jennifer Swainson
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Psychiatry Research Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772598721000180